robertwilson@rarecyte.com, Author at RareCyte

robertwilson@rarecyte.com

There are no posts on the list.

Neil has over 30 years’ experience scaling global Life Sciences commercial organizations and driving adoption of advanced omics and analytical technologies. Neil has deep experience building high-performance teams, defining go-to-market strategy, and positioning innovative platforms for market leadership. Prior to RareCyte, Neil was the Chief Commercial Officer (CCO) at Curio Biosciences (acquired by Takara Bio USA), CCO at Rebus Biosystems, SVP Commercial Operations at Dovetail Genomics, VP Sales & Marketing at Biodesy, and VP Sales & Marketing at DVS Sciences (acquired by Fluidigm). Neil’s experience also includes positions of increasing responsibility at Sequenom, Millipore, Quantum Dot, and Affymetrix. Neil holds a BS in Biological Sciences from California State University Chico and completed Miller Heiman large account management and strategic selling training.

LinkedIn profile ➝

Introducing Orion HT